and snap i'd buy that with a ten stop to the downside >> guy >> 10:00 tonight, eastern time >> "big shot." >> and pacific time. check it out "big shot. clf, melms >> thank you for watching "fast."shot. don't go anywhere. "mad money" with jim cramer starts right here. my mission is simple to make you money. i'm here to level the playing field for all investors. there's always a bull market somewhere. and i promise to help you find it "mad money" starts now hey, i'm cramer. welcome to "mad money. welcome to cramerica other people want to make friends. i'm just trying to make you a little money my job is not just to entertain but to teach so call me at 1-800-743-cnbc or tweet me @jimcramer this was one of those days where unexpectedly it all came together for the bulls

dow advancing 47 points. s&p gained .52%. but the nasdaq jumped .9%. ♪ hallelujah ♪ with today's strength it's important to note that the nasdaq and s&p both finished the month of february at record highs. something i regard as quite simply amazing given all the woe and worry that we endlessly hear about. what fueled today's rally? it's actually a complex formula of emotion and empirical data ware widespread sense of negativity gets proven wrong and remember, why we like stocks shines brightly. smashing the all-encompassing gloom. >> the house of pleasure >> let's start with the setup. we get data from all sorts of places the census bureau, bureau of statistics, bank of st. lou, s&p global, commerce department. often these figures don't mean a hill of beans but periodically when the fed is in play they can mean everything. especially if you know that the fed cares about some pieces of data more than others.

right now the fed is very much in play. we've been getting some hot economic data of late. they don't have much reason to cut interest rates which is unfortunate because rate cuts are like oxygen for the bulls. fortunately, there are numbers that can counteract the no rate cut scenario and for example, today we got a cooler than expected u.s. personal consumption expenditures number from the bureau of economic analysis in the commerce department. i know that sounds like authentic wall street gibberish. but this number is the fed's favorite gauge of inflation and it came in right going to this personal consumption expenditures reading, or pce, we have a bunch of wayward days where the market was doing nothing because traders didn't want to get caught they didn't want to react to anything given this number's waiting in the wings this morning after the ridiculous hours i get up i'm watching cnbc and you can see the s&p 500 futures going down, down, down, down, down based on nothing. the stock and much larger bond market, everything's selling off with real intensity as the

morning marched on again, no particular reason other than fear. and then at 8:30 a.m. we get the hallowed pce report and frankly it was perfect >> the house of pleasure >> not too hot, not too cold just right up just 2.8% year over year. fed likes that number. bond yields fell, s&p futures reversed and the bears were completely picked off, leaning the wrong way. now, if s&p 500 futures had been up ahead of this number, which the fed regards as all important, it wouldn't have mattered right? we wouldn't have had a big gain. but we were down because there was so much negativity and that made all the difference. if you're bullish you live for days like this one where all the supposedly genius short sellers need to either undo their bets or get stampeded do you know what the biggest negative bet is in this market think about it do you know what the self-described bubble bears have been waging war against, telling you it's all phony, hokeum yeah artificial intelligence. that's what. we've seen stocks fly up on hopes of ai for months now

lately it kind of felt like they were topping out, didn't it? lots of stocks have been doing just okay in the last few days we did have an excellent nvidia number last wednesday. however, on wall street eight days is a long time ago and we haven't had any new data points since then i kept hearing the nvidia quarter marked the peak of the ai craze so put yourself into the heads of these wiseguy professionals first they think they're going to win on this inflation number that's toto for the bulls, toto meaning turn off the oxygen. wrong. second, they feel like with a little bit of pushing maybe today could be the beginning of the end of the ai bubble pop. for that to happen, though, we'd need some ai disappointments, tech negativity. these things don't roll over in a vacuum, do they? there was a moment last night where the bears felt incredibly emboldened if you watched last night's show you know the company gave you a pretty darn disappointing outlook. at the same time salesforce, a dow component, gave you a forecast that was a couple percentage points light of what the bulls were expecting and people were saying hey, you know

what >> dive! >> that was wrong too. okay it was indeed disconcerting but a close reading of the conference call tells you companies are hiring salesforce like mad if you heard marc benioff on the show you would have known that the data cloud they have helps enterprise improve sales ceo marc benioff said this is the best it's ever been for the company in one particular cloud that they're offering. it's a virtual explosion of spending on ai marc joins bill mcdermer from service now in talking about how big this ai opportunity is, not in the future, right now actual numbers that's right actual numbers not pie in the sky so a stock that was down 15 points on its outlook actually glielz v climbs out of the hole after the conference call and retreats at the opening today then blasts off during the day and finishes up 3%, taking a lot of stocks with it. ♪ hallelujah ♪ we get a report from the usually tempered analyst who threw a

grenade to the bears with a note that said still wildly bullish on satellites. blew the bears to smithereens. he loves the ai thesis next week hp, the old hewlett-packard, will have nvidia's jensen huang on stage talking about the new artificial intelligence pc that hp's been talking about endlessly and i've been talking to you about at last this is going to be a seminal thing. you'll be talking to your pc all day instead of doing work. then to make things really interesting best buy, the electronics chain, offers a fairly tepid view of things but says there are two standouts to watch. a samsung phone that is full of ai that is selling well. and meta's ray-bans. the ones i keep telling you about are selling just like hotcakes they take pictures, they take calls, they take messages, and by the way, they look like regular ray banz, not like you're an idiot walking around town all these tidbits combine to send up some of the now magnificent seven, ragtag seven

meta, alphabet, amazon and of course nvidia, which is a given the redoubtable chance in vegas next week. there are a lot of people worried about the decline in the stock of apple i see it just as a lull, a lull that will refresh. i'm not changing my view, which is own ittish don't trade it and if you listen to the ceo of best buy, corey barry, talk this morning about the red hot samsung phone, you can see the future of what apple has to be working on ai in your hand. what do people like about the samsung phone? a lot of things apple can duplicate or exceed. the circle to search function. how about generative et cetera to transform your photos, find the right words fast with a chat assist and maybe most exciting thing, live translation on the phone. okay, i know, it's a samsung phone. but can you imagine how hard it is to get anyone to buy a samsung phone? and it is selling. i mean, come on. if apple can just get a bead on half of these things for the iphone 16, then you know it will

be an incredible upgrade cycle you're selling apple into perhaps the new generation of ai there were some laggards today i get that that said i wouldn't be surprised if the rally continues tomorrow given that the pc and server giant dell shot the lights out after the close today. one more data point showing that tech's got a lot more strength than people think. but the bottom line, what mattered was the one-two punch of an economy that's just right, meaning still potentially ripe for rate cuts, it could happen and the fact that ai is alive and well it reminded us why you can't leave stocks even if you think you've had a nice run so far this year and it would be safer to move to the sidelines stay long today said, and you can indeed make more money than those bonds that beckoned so many in a way too crowded trade that's not for us. macy in illinois macy >> caller: boo-yah, jim.

here's mazey >> fill me in, chief >> caller: i'm 8 years old and i love playing roblox with my best friend and i want to know what jim thinks about roblox stocks >> that kid's got horse sense. a lot of it is because the kids realize this is a smart way to learn. i wish i had it. all we ever did was play monopoly and i would dump the board if i lost. let's go to smitty in south carolina smitty >> caller: jimmy chill, how are you today? >> i'm chilling. what's happening >> caller: good. jimmy, great meeting last week, by the way fantastic. but jim, the reason for my call today is i currently own crowdstrike and now with palo alto trading a little bit less than crowdstrike would you recommend i flip over to palo alto -- >> i'm not going to tell you to sell george. i mean, look, palo alto was brutal, i know, but -- because you obviously saw the presentation we pushed aloe alto very hard and made some money back there's no reason to sell what

george has got george is doing incredibly well. speaking of george kurtz, the ceo of crowdstrike let's stay long and enjoy. let's go to ann in indiana ann. >> caller: hey, jim. thanks for taking my call. it was a wonderful annual meeting, as a club member. really appreciate your efforts and how hard you work. but calling about cava so i got on about a quarter of a position i just trimmed after the parabolic move but could you please help me figure out if i don't get a full position on how do i know when to just close it out and move on to the next phase? >> you know you cut me to the quick. that's one of the toughest questions. the cava quarter was brilliant you're playing small position. let it run that's all i can say if it ever drops back to 40 we'll pull the trigger but just let it run. today's performance reminded us why you can't leave stocks for the sidelines. even if you think we've had a nice run so far in 2024.

today's moves say don't go on "mad money" tonight hormel reported a quarter that was just nuts i'm learning more about how the planters acquisition helped drive the company's strength and i've got to tell you -- >> they know nothing >> the sellers know nothing. then i added a name to our charitable trust for the investing club after talking to the ceo at the jpmorgan health care conference. i'll reveal what it is and why i think the stock has a lot more room to run. and sempra announced $40 billion. what it's going to mean for climate change so stay with cramer. >> announcer: don't miss a second of "mad money." follow @jimcramer on x have a question? tweet cramer #madmentions send jim an e-mail to madmoney@cnbc.com. or give us a call at

1-800-743-cnbc miss something head to madmoney.cnbc.com.

whoa, how did you defeat them? with a little kung fu strength and by connecting my devices to the most powerful force of all. skadoosh. hah, huh? cool right? amazing. harness the power of xfinity internet and stay connected to the things you love. ah, they'll be like this for hours. hello dad, hello dad, hello da. uh-oh. good bunnies. ahh!

the s&p 500 had an unlikely champion today in hormel foods, which sent the index higher as it rallied nearly 15% in sfons response to a phenomenal quarter. i call hormel an unlikely champion because the whole packaged food space has been out of favor for a while now, wall street's worrying about the weight loss drugs. plus hormel had a big gap down last october when it rolled out some financial targets that wall street didn't love a little over two weeks ago the stock hit a 52-week low. but this morning hormel report aid stunning quarter with better than expected sales driven by 4% volume growth, not pricing, volume, and a 7% earnings beat off a 34-cent basis. that's really big. dmjt raise the full-year forecast the quarter itself was so strong it sent the stock into the stratosphere

can it keep flying why don't we check in with jim snee, president and ceo of hormel foods mr. snee, welcome back to "mad money. >> it's great to be back with you, jim thanks for having me >> jim, this is just a stunning quarter. a lot of people didn't see it coming can you give us the breakdown of what made it happen? >> yeah, it was a really strong quarter, jim, and what was nice about it, it was so broad-based in the success it was across all our business segments, retail, food service, international. marked improvement in our supply chain over a year ago. inventories down, fill rates up. really by any measure as you look across the spectrum a really high-quality beat by the team >> now, there's been volume growth in food service and international. there was really kind of a -- reminds me of a pure growth company, not what i'm seeing from a lot of the other companies in your category >> yeah, our food service business really is operating from a strong advantage position we've talked about it over the

years. where it is so mature in terms of the portfolio they've developed, the relationships they've developed, the direct selling organization, and it's all about creating solutions for the operators. our international business had a tough year last year it bounced back earlier than we thought this year. but we know that they're on track for another good year in 2024 and that's really nice to see. >> i always knew and we talked many years when you got planters thatplanters would become a standout because it's really the only brand we want in the segment frankly but i didn't think you could come on this strong what do you think happened that it just really ignited >> yeah, well, we're really excited. we really hit our stride with planters, jim. again, we think about the innovation that we've put into the market and that we're bringing forth and so i think we sent you some great innovation with our planters duos, which is really exciting last year we launched our flavored cashews and a specific advertising campaign against it. we've gained distribution. we've increased our advertising

against it we've changed our advertising strategy the last couple years we'd done super bowl ads and this year we've moved to an always-on campaign, a new campaign "aw nuts," which is really connecting with consumers. the one thing i'd mention -- i mentioned flavored cashews what's really exciting for us is the way it's connecting with a younger consumer it's bringing a younger consumer into the category. and that's really what we knew we could do. >> i'll say something else is happening in addition to that, jim. on these glp drugs a lot of people worry about food companies. i look at your portfolio, and it is uniquely set up because people are getting a protein that's what all the doctors will tell you that the big problem with glp-1s is frailty because it loses muscle as well as fat. but i look at your portfolio, you've got the protein portfolio. >> i couldn't agree more, jim. we are so well positioned with this protein portfolio that we've built. one of the things we are very

intentional about is always thinking about the balance and so we think about affordable protein. we think about indulgent protein. we think about natural and organic protein. we've got meat, non-meat protein. so really no matter how you think about our portfolio you're going to encounter protein, which is a really important part of any diet program and especially with these new weight loss drugs that are all the rage >> it also seems like you're gaining share in almost every single one of your verticals >> yeah. our team's doing a great job i mean, we're maintaining or gaining share with so many of our retail brands. you mentioned planters i'd be remiss not to mention the skippy brand and like i said at the outset, this is a really broad-based beat so that's what's really exciting for us within our reel r retail segment strong volumes, food service, continuing on their trajectory, and really nice recovery in the

international business >> we can't forget applegate still going strong the whole time, right? >> absolutely. steven mcdonald says hi. >> oh, thank you >> the portfolio continues to resonate with consumers. we continue to innovate with applegate and expand distribution it's on target it's on trend. and it's a business and a brand that we continue to invest in. >> justin's is a brand i see young people eating all the time just knowing enough young people to know this is the preferred brand. how big can that name plate be >> yeah, you know, it is a bit of a specialty brand when we think about nut butters in particular almond butter, that is more of a niche play but it does have a broad-based portfolio and we've seen great growth in confections. you know, and so when i talked earlier about having value protein or indulgent protein, that's a great example of

indulgent protein that sets our portfolio up for success >> now, last thing i need to ask is i can't avoid talking spam, teriyaki spam, maple spam. boutique items collector's items? good to eat? what do you think? >> great to eat, jim you know that. maple spam is the latest flavor that we've int introduced you think back to pumpkin spice spam, figgy pudding spam now maple spam i'll give you a sneak preview. we've got a couple of really neat flavors still yet to come in the next year or so and so you have my promise that when those are ready to go i'll bring them back to you but the spam team continues to do a great job the spam brand continues to resonate with consumers. and again, back to the topic we just talked about, a great affordable source of protein that is meeting all the consumers' needs >> well, look, you've got the right portfolio. it's terrific. the numbers are shining.

congratulations, jim, for just an amazing quarter good to talk to you again. >> good to see you, jim. >> that's jim snee, ceo of hormel, hrl. amazg arr.inqute the best in the whole food group. "mad money's" back after the break. power e*trade's award-winning trading app makes trading easier. with its customizable options chain, easy-to-use tools and paper trading to help sharpen your skills, you can stay on top of the market from wherever you are. e*trade from morgan stanley

power e*trade's easy-to-use tools make complex trading less complicated. custom scans help you find new trading opportunities, while an earnings tool helps you plan your trades and stay on top of the market. e*trade from morgan stanley

nice to meet ya. my name is david. i've been a pharmacist for 44 years. when i have customers come in and ask for something for memory, i recommend prevagen. number one, because it's effective. does not require a prescription. and i've been taking it quite a while myself and i know it works. and i love it when the customers come back in and tell me, "david, that really works so good for me." makes my day. prevagen. at stores everywhere without a prescription. earlier this year we came back from the jpmorgan health care conference in san francisco. we were brimming with ideas for

new health care investments and i gave you my top five among them we already owned eli lilly for the charitable trust it's up more than 20% since then you know why i love that story but there was another big story from the jpmorgan health care conference that caused us to buy one of these stocks for the charitable trust i'm talking about abt. yeah, abbott labs. the medical technology company we started buying abbott on january 29th after the stock pulled back a couple bucks and since then it's off to a nice start. the charitable trust is now up more than 5% in the position which of course you would know if you joined the cnbc investing club and i think abbott, frankly, i think it's just getting started. which is why tonight i want to walk you through the story in depth and why i like it so much. especially after its most recent quarter. of course i've been a fan of abbott labs for years. this company's a terrific innovator, particularly in diabetes management and the cardiology space the stock was a long-term outperformer under the legendary former ceo miles white who passed the torch to robert ford in march of 2020 we used to own abbott for the charitable trust too, holding it from 2017 until 2022, and we

called a double by the time we sold it. we had to sell it back then because abbott had a huge covid testing business and that was going to unwind as the pandemic went away. we didn't want to get caught with a covid hangover. abbott had indeed that post-covid hangover as the year over year declines from their covid franchise obscured the basic strength in the rest of their business then adding insult to injury the stock sold off last summer as part of the glp-1 weight loss drug scare when investors dumped anything that seemed to be hurt by a decline in obesity or in diabetes by the time the stock finally bottomed just below $90 last october it was down more than 37% from its all-time high in december of 2021 that's a big decline since then abbott's been on a roll the stock had already charged back to 100 and change by the time we spoke to robert ford at the jpmorgan conference. the case is pretty simple. with the post-covid hangover fully in the rearview mirror wall street can go back to

appreciating the strength of abbott's core businesses and there's a lot of strength here as the company has double-digit growth across most of its main divisions. but the spring factor for me came last month when ford explained that the growing adoption of glp-1s is not a threat to abbott labs. if anything he sees it as an opportunity. people who get prescriptions for glp-1s tend to become better stewards of themselves they take care of themselves better and if they have diabetes that means they're more likely to use abbott's continuous blood sugar monitor. at the same time the protein shakes and powders will sell much better because glp-1 users need to consume a ton of protein to prevent themselves from losing too much miss muscle mass just as important on january 24th abbott reported and initially wall street didn't even like it i thought there was a lot to like right at the top but the company delivered a small revenue beat covid test business 14.5% of growth in the medical device

division specifically. although the earnings were in line abbott's full year forecast which is what i was looking for was strong for me the big takeaway from the quarter is abbott's core growth rate the organic growth rate excluding the covid business is structurally higher than it was before the pandemic and that was pretty shocking. pre2020 they averaged 78% organic growth that's already great, right? but this year they're talking about 8% to 10% organic growth, excluding the covid business that's remarkable. when ford was asked about this on the conference call he explained abbott used its covid testing recall to reinvest in the business improving some already quite strong franchises and now those investments are paying off ford went through each of the company's businesses and laid out everything abbott's done to improve them paying a very compelling picture of the whole company i ate it up. if you want the company's full-year earnings per share guidance 4.50 to 4.70 it was nor in line with what wall street was looking for. it wasn't a miss i think management is offering a projection they feel confident can take a beat.

i also think abbott has increased its dividend for 52 consecutive years, making this a true stock dividend aristocrat although right now it seems less impressive than it used to given that it's less than 2% but that's because the stock's going up so much we got some big news on the product development front. in january the company announced their volt pulse field oblation system for patients with heart rhythm disorders like atrial fibrillation, has already started being tested on humans which that is a very big sadly huge market. abbott thinks they can get a thumbs up from the fda for its u.s. clinical trials sometime in the first half the year. i want to highlight one more development on january 31st abbott announced the launch of its protality branded protein drinks these are specifically designed for people taking the glp-1 drugs. those are the ones that cause you to lose both fat, okay good, and muscle, bad, in roughly equal proportions. one day they'll make it so you can only lose fat.

but right now you can get real frail using these medicines. abbott strikes this protein shake as the first product to support the growing number of adults in supporting weight loss while increasing muscle mass and nutrition. abbott's dpifth business could benefit from the glp-1 theme but i didn't realize the company would try to maximize the opportunity by developing a new product targeting the glp-1 crowd. i think it's a smart move because as you get older if you take these drugs you can get very frail you can get hurt. this is what you need because you tend not to want to eat dinner because you're so full from lunchtime when we get back from san francisco after the jpmorgan health care conference in early january i gave you a few of my top ideas in the health care sector and those names have on average done pretty well over the past month and a half but other than eli lilly the one i like best is abbott labs, which is why we got back into it after the charitable trust bottom line we've got a nice little gain in abbott labs for the charitable trust but we wouldn't have bought it if we only thought the stock had 5%

upside i'm expecting much bigger gains over time. so it's not too late to i can p up some abbott yourself. and hey, to put on my shameless self-promotion hat if you join the investing club we'll help you do the homework. let's take calls let's start with joe in north carolina joe. >> caller: hey, jim. hey, listen, again, i want to thank you for your advice over the years. i've been a viewer since day one, and your regards in to apple, microsoft, nvidia, have allowed me to retire after my military career and spend a lot of time with my family so god bless you. >> oh, my. first thank you for serving. and second, it means a lot to me that you pointed some of these out. these are not -- this is a big deal for me. and to hear it from someone like you, who has served this country and done so much good and you've been able to retire, well, then we did good ourselves. and that makes me and i'm looking at regina guilden, my unbelievable executive producer, she and i were with each other on last weekend's investment club conference. i'm not tearing up but i'm pretty excited about what you

said thank you very much. >> caller: jim, can i ask you a quick question in regards to -- >> sure. >> caller: i was on the show a cull couple weeks ago in the lightning round and i asked about crispr it's a gene editing therapy. i know it's a spec stock i bought it in the 40s it's in the 70s or low 80s right now. but my question to you is i got a couple hundred shares plus my retirement income. would it be okay to sell a covered call, take out -- >> you know, don't want you to -- sir, you'd be capping your up side. if you really feel like you don't think there's that much up side, you want to do that, i suggest that you sell a quarter of the position rather than cap your upside. i don't like that. if something goes wrong, you have to buy back the call, there's just a lot of different things that can go wrong in that situation. let's take a quarter off the table and as it goes, say, another 10%, 15%, take another quarter off and then we're just playing with the house's money

big-time that's my suggestion to you. thank you for the incredibly kind words by the way, i happen to like crispr very much let's go to jeff in new york jeff >> caller: hello, mr. cramer this is jeff from sotis, new york on lake ontario >> there you go. beautiful. what's up? >> caller: everyone in this area is very excited about the full solar eclipse that's happening april 8th. due to our vicinity to the lake and the chance of clouds there's uncertainty about being able to see this amazing event this reminds me of the company i'm calling about that has been rising in the last four months but has hit a snag recently while waiting for uncertain approval by the fda. can you help predict the future and tell us if there will be sunny skies for us and avitae medical, rcal? >> i almost feel better for the sunny skies. i don't know this company. i think people should understand, i don't know the calls ahead of time and i don't know the stocks ahead of time. and i do not know avita medical. i have to do some work

i hope you see the solar eclipse. i love these two calls i'm expecting much biger gains to come. robert ford's doing a great job. that's why i think it's not too late to pick up some abt yourself much more "mad money" including the ceo of sempra. what a quarter natural gas prices not recovering from the peak what should we make of the state of natural gas how about solar? how about hydrogen they know it all we'll talk to the top brass. then we're hearing a lot about the impact of the glp-1 drugs i just mentioned what is the single best way to invest in the theme? i'm going to give you some names beyond just abbott like i did. and all your calls rapid-fire in tonight's edition of the "lightning round." so stay with cramer!

hey you, with the small business... ...whoa... you've got all kinds of bright ideas, that your customers need to know about. constant contact makes it easy. with everything from managing your social posts, and events, to email and sms marketing. constant contact delivers all the tools you need to help your business grow. get started today at constantcontact.com constant contact. helping the small stand tall. (vo) explore the world the viking way from the quiet comfort of elegant small ships with no children and no casinos. we actually have reinvented ocean voyages, designing all-inclusive experiences for the thinking person. viking - voted world's best by both travel + leisure and condé nast traveler.

learn more at viking.com. rylee! from rylee's realty! hi! this listing sounds incredible. let's check it out. says here it gets plenty of light. and this must be the ocean view? of aruba? huh. this listing is misleading. well, when at&t says we give businesses get our best deal, on the iphone 15 pro made with titanium. we mean it. amazing. all my agents want it. says here...“inviting pool”. come on over! too inviting. only at&t gives businesses our best deals on any iphone. get iphone 15 pro on us. (♪♪)

now that earnings season has mostly wrapped up i wanted to circle back to some of the great quarters that seemed to float under the radar. take sempra, one of my favorite growth utility companies it's got regulated gas and electric utility exposure in california and texas they had a big energy infrastructure business with natural gas pipelines in mexico. they've got a liquefied natural gas export facility in louisiana and more export terminals on the way. earlier this week sempra reported a nice earnings beat more important i thought was management raised the mid point of its full year earnings guidance and gave a strong outlook for their 2025 fiscal year as well also raised -- of course the stock's down 5% for the year because the market's got little interest in utilities but is it possible to buy into i aterrific long-term growth story at a discount let's take a closer look with jeffrey martin, chairman president and ceo of sempra, to learn more about what's going on at this terrific utility mr. martin, welcome back to "mad money. >> jim, it's great to be back on

with you >> i've thrilled you're here, jeffrey. you're spending $48 billion worth of investments what will the people be getting for that money and why do you need to spend so much? >> yes, sir. it's an exciting time for our company. we increased our capital plan roughly $8 million and that will allow us to fund several strategic initiatives. number one, grid modernization as well as key investments in safety and reliability plus it gives us some investments to allow us to move renewables onto grid at a faster pace so i think over half this increase, jim, will be al kated to our texas operations where we're seeing significant growth. the balance will largely go here in california where we serve just over 25 million consumers i think the key takeaway is a $48 billion record capital plan really lays out a road map for our future growth and should support rate-based growth at our utilities at between 9% and 10%. >> could you give us a feel with texas and california you've got some -- you're a huge percent of the gdp in our country frankly those two states are

like countries what are the states of those two? because we know politically they're very different but it seems like both of them are doing pretty well. >> yeah. i would just start by saying this you know, remember, we're an energy infrastructure company. and you and i have had this conversation before, but we've long talked about the importance of strategy. it's an opportunity to organize our assets and employees and investment to create a competitive advantage in the marketplace. and we've done that in two key ways number one, making sure we build leadership positions in large economic markets just like texas and california and secondly, making sure we're investing narrowly in the energy grid where we think it has the best risk-reward return for our investors. i'll start with california we've got a $24 billion program here, jim. this state has made a commitment to be an energy leader and it really translates into electrification of the economy and for our company as a large network owner our job is to green the grid, make sure we

make investments in safety and reliability, and that translates into a $24 billion campaign in the state of california, moving briefly to texas that economy is on fire. electricity demand is going up the need to modernize and expand the grid is increasing, and our business there, we're the majority owner of encore, it's the state's largest utility. and they too have launched a $24 billion capital program. so it doesn't stop there we're also making lng investments in texas and i've told people, we expect to be the largest capital investor in the state of texas through the end of this decade >> very impressive you're going to be the biggest creator of jobs in this decade you mentioned about electrification in california. i understand that even though there seems to be this ennui about evs in the rest of the country electric cars are still selling very well there and 23% of san diego has rooftop solar so california's still going and going with what i record as

being a very fear of climate change strategy. >> there's no question, this vehicle leads the united states in electric vehicle penetration. and here in san diego we've got one of the highest penetration rates of any city in the united states with over 140,000 electric vehicles. and you're right, we lead the nation in supporting rooftop solar and beyond that roughly 55% of all the power we deliver to our customers comes from renewables here in the state so we're very serious about electrifying the economy and it really bodes well for those folks who are making investments to modernize the grid to meet these public policy mandates >> now, there were people who -- really a shudder went through me for knowing what you guys want to do with lng when the president said listen, we've go to pause development but you are doing things already that can't be stopped, correct and these are gigantic projects. >> yeah. it's really interesting. let me give a little bit of context to your viewing audience today the united states is the

global leader in the export of liquefied natural gas, or lng. and going forward we expect that that will continue and have the opportunity to actually double america's capacity because of the continued demand we see from both europe and asia as well as the need to displace coal from power production the key takeaway on the department of energy issue is it is impacting the sector, but at sempra we believe the long-term fundamentals of lng are intact particularly for uslng and our company, jim, you hit it correctly, we've got two very large construction projects that are fully permitted and moving forward and we have a series of other development projects that are fully permitted. here's the key takeaway. it's important for people to understand that the united states is truly a force for good in the global energy markets and you know this better than anyone else. we have the deepest capital markets. we've got the rule of law that allows for sanctity of contracts, which is essential for international commerce and jim, we have an abundance of

natural gas. and that means low price and low price volatility so from our perspective we're fairly confident that this permit issue gets resolved, but we're also confident that america will continue to be a global leader in the energy markets and with respect to sustainable business practices at sempra we believe those two things can co-exist together, and the real winner if we do our job will be the american worker and america's allies that get improved energy security and a lower carbon footprint >> well, you've got a view of the world that i think every american shares. that's a terrific way to view sempra, which you know i think is the only utility that i want to own because you've got a great plan going forward. no, i mean it. a growth utility i love that. jeff martin, chairman, president and ceo of sempra. thank you so much, jeff. great to see you again >> thank you, jim. good to be on with you >> "mad money's" back after the break.

to build the electric vehicle of the future, you need partners. mining partners. technology partners. education. supply chain. energy. what if one partner could do it all? that partner is ontario, canada. with all the critical minerals to make electric vehicle batteries. 65,000 stem graduates per year. one of north america's largest i.t. clusters. a fully integrated supply chain. all powered by one of the cleanest grids in north america. ontario. your innovation partner.

( ♪♪ ) it is time it's time for the "lightning round" on cramer's "mad money" -- play until you hear this sound and then the "lightning round" is over. are you ready skee-daddy tim for the "lightning round" on cramer's "mad money" let's start with chuck in arizona. chuck! >> caller: boo-yah, jimmy! >> whoa. fired up way to start the "lightning round." what's going on? >> caller: your 979 film "cramer vs. cramer" was a favorite of mine >> unfortunately, it was fact not fiction. what's going on? >> caller: back in december

sharon epperson reported that 2024 is going to be a record for engagement you need to get your girls some bling rings. i believe signet jewelers will be in the right space for this event. >> i agree with you entirely she's been changing the stores radically and yet people are still well behind because the multiple's way too low you've got a winner there. let's go to joshua in north carolina joshua >> caller: boo-yah, jim. >> boo-yah >> caller: how are you doing today, buddy >> not bad how about you? >> caller: i'm doing great i'm doing great. i want to thank you for all the help you are out there for all us individual traders. you're number one. thank you so much for that and i love the sound board yeah my question is today on eqix it's looking good to me over here >> i can't recommend it. it's just up so much if i say let's buy it right here, it's just on a tear but i do like it very much that's how i'm going to put it now we'll go to jason in arizona. jason. >> caller: hey, how are you doing, jim >> i'm doing well, jason

how about you? >> caller: i'm doing pretty well too. nice and sunny out here, even on the last day of february >> can't beat that >> caller: i have a question regarding the stock for insy >> smart consulting company. i've liked it -- literally i've liked this -- it was the first company that i had -- i discovered it like many other people because it's based in india when i realized wow, these guys are just a great way to do business so i like the stock. let's go to sam in colorado. sam. >> caller: jim, how are you doing? >> i'm doing well. how about you, sam >> caller: jim, i'm all right. i want to talk to you about a company that i don't think is getting the credit it deserves one thing going on across our great country right now is we're seeing a buildout of single-family homes and industrial plants. all across the country >> true. >> caller: onshoring continues to be a thing that's happening one of the things going into all that construction is steel rebar. and despite the steel industry seeing a little bit of a

slowdown, commercial metal company ticker symbol cmc -- >> i know this is going to sound like a copout. it's a very boring company and people don't like boring but it sells at a very inexpensive price. and i think you're right i think it's a winner. let's go to george in arizona, please george >> caller: boo-yah, jim. george from the valley of the sun, phoenix or should we be calling this the valley of the chip jim, we've had huge expansions of on semi, taiwan semi but i want to ask you about a local company. amkr huge expansion out here. >> you've got a winner you're absolutely right about everything you said about the semiconductor industry and they are integral and you are in the zone with that one let's go to lou in connecticut lou! >> caller: hi. jim. i didn't expect you so quick jim, i just wanted to ask you about on holdings. you know, it's had a good run. i just wanted to know if i should buy some more at the current price. >> i'll tell you, there is going

to be what's known as a lockup expiration where soft bank is going to be able to sell a lot of stock i think they will sell a lot of stock. if you want to buy some right now and then wait for that lockup to end, that would be the best way to do it. and that, ladies and gentlemen, is the conclusion of the "lightning round"!

power e*trade's award-winning trading app makes trading easier. with its customizable options chain, easy-to-use tools and paper trading to help sharpen your skills, you can stay on top of the market from wherever you are. e*trade from morgan stanley power e*trade's easy-to-use tools make complex trading less complicated. custom scans help you find new trading opportunities, while an earnings tool helps you plan your trades and stay on top of the market. e*trade from morgan stanley

democrats agree. conservative republican on t steve garveyket. is the wrong choice for the senate. ...our republican opponent here on this stage has voted for donald trump twice. mr. garvey, you voted for him twice... as your own man, what is your decision? garvey is wrong for california. but garvey's surging in the polls. fox news says garvey would be a boost to republican control of the senate. stop garvey. adam schiff for senate. i'm adam schiff, and i approve this message.

you've now heard a lot about the fabled glp-1s, the weight loss drugs from eli lilly and novo nordisk taking the world by storm. that's why i can't wait to see tonight's documentary about these particular drugs by my colleague melissa lee. it's called "the big shot. and it's on tonight at 10:00 p.m. since this is "mad money" i want to talk about the best way to invest in this amazing wave sweeping the globe first as the documentary shows these drugs are big, and i mean

really big in this country more than a third of our population's obese, more than 2/3 overweight that's a lot more than the 5 billion people that are currently taking these drugs second, what matters for the most isn't demand, it's supply eli lilly's the only company that can afford to provide the supply of these drugs and they're doing it by building necessary plants novo nordisk doesn't even have money to do it nor can viking therapeutics everyone's so excite about even though their drug's only in phase two and their share offering today cratered the stock. that's why i stand by the idea i've been hearing from legendary investor ken langone for a long time eli lilly will be the first drug company to reach a trillion-dollar valuation. that's almost $300 million above where the stock is right now third and most important i believe there's something going on that isn't talked about enough the exact that these glp-1 drugs are really about willpower two kinds of willpower there's a gigantic industry promoting diet and exercise as a way to lose weight we know diet and exercise can work but there are many people

who lack the will tour to maintain that regimen. hence why over 100 million people in the country are obese. diet requires a massive amount of willpower, and as a country we're pretty judgmental against those who don't have it. that's awful all around but it's the truth and we have to accept that's the reality this is "mad money," not mad body positivity. what these glp-1 drugs do is turn the entire health and wellness paradigm on its head. most humans don't have enough willpower to maintain proper diet and exercise even though it would make a difference. these drugs give you the willpowering not to eat fattening foods, the willpower not to drink liquor, which is largely sugar and real bad for you. of course that comes at a cost the people who are successful on these glp-1 drugs don't get much joy out of food, nothing tastes special and liquor doesn't have much taste at all. that means you end up losing watt real fast that's the secret sauce to destroying obesity as tonight's documentary shows conclusively these drugs can also prevent people, especially younger people, from getting

type 2 diabetes. you know who has propensity. one self-administered shot a month. since the drugs make you feel it full by dinner-time any decent sized lunch fills you up for the rest of the day, they also have another down side. frailty because you lose equal amounts of fat and muscle. dinner typically kanlts proteins and you need protein to maintain strength that's why abbott labs is smart to offer this protality protein drink i mentioned. if these glp-1 drugs are big as i think they will be, the answer is yes and i'm unremitting in my fear of the processed food and beverage stocks even as they all claim they haven't seen any decline in sales because of the glp-1s i say of course not. i get that it's too early but if you have endless willpower you're not going to be eating twinkies, think smucker and you aren't going to be pounding down liquor think diageo those are the kinds of stocks i think you can't own. this is "mad money," not mad diet and weight loss but i thought it would be an appropriate prelude to melissa's amazing documentary tonight at 10:00. these drugs are game changers. there are so many other conditions caused by obesity

that could be knocked out. many of those conditions are fatal. the glp-1s will eventually come down in price and they'll be covered by insurance it's a big reason why we own both lilly and abbott labs for the charitable trust and it's why i think you should own them too. i like to say there's always a bull market somewhere and i promise to try to find it just for you right here o right now on last call, stocks smashing records but only an elite few have gone unscathed in this elite rally. jamie diamond lighting up the state, doing business in new york. you will hear from billionaire developer don peebles. could the spiraling cost crisis be contained ? white house hopeful robert f kennedy junior joins us with the reaction. shares of a major regional bank tanking right now. the breaking developments, plus the ozone big revolution is here. we take